On the heels of our recent post on our presence at this week’s DIA Japan 2015, BBK welcomes Philip Gregory, the General Manager of 乔治临床( George Clinical ) – CRO China as our guest contri […]
了解更多
New data presented at the American Society of Nephrology meeting in San Diego last November offers new hope to people with diabetes at risk of kidney disease and kidney failure. They suggest a new class of glucose-lowering agents, sodium glucose co-transporter type 2 (SGLT2) inhibitors, may be effective in preventing kidney failure. This data has […]
了解更多
Globally, there are millions of people that could benefit from an intensive lowering of blood pressure (BP). An individual with lower BP decreases their chances of suffering from any cardiovascular events such as: stroke, heart disease or heart attacks. A new study shows that lowering blood pressure to less than 140 mm Hg, the current […]
了解更多
If you haven’t thought about diabetes before, it is time to stop and think for a minute. Why, you might ask? The World Health Organization’s figures from last year estimate over 350 million people worldwide have diabetes. The emerging epidemic is attributed to the rapid increases in overweight, obese and physically inactive individuals. Diabetes is […]
了解更多
Access to large markets where clinical trials that can investigate real patient needs, and do so in a rapid fashion, is invaluable for clinical research organisations. One such example of 乔治临 […]
了解更多
Recently, the FDA said it will review possible heart risks associated with saxagliptin, a widely used diabetes drug. […]
了解更多
A diabetes epidemic is upon us, despite improved knowledge and therapy on this disease. The recently published 6th edition of the International Diabetes Federation Atlas provides some alarming figures.
了解更多
